Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: HIKMA CANADA LIMITED
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02304341 | HIKMA CANADA LIMITED | 0.9% SODIUM CHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | SODIUM CHLORIDE | 9 MG / ML |
| Marketed | 02459906 | HIKMA CANADA LIMITED | ACETYLCYSTEINE SOLUTION USP | Human | Yes | ETHICAL | 1 | ACETYLCYSTEINE | 200 MG / ML |
| Cancelled Post Market | 02525909 | HIKMA CANADA LIMITED | AMIKACIN SULFATE INJECTION | Human | Yes | PRESCRIPTION | 1 | AMIKACIN (AMIKACIN SULFATE) | 250 MG / ML |
| Marketed | 02432188 | HIKMA CANADA LIMITED | ATROPINE INJECTION BP | Human | Yes | PRESCRIPTION | 1 | ATROPINE SULFATE | 0.4 MG / ML |
| Marketed | 02432196 | HIKMA CANADA LIMITED | ATROPINE INJECTION BP | Human | Yes | PRESCRIPTION | 1 | ATROPINE SULFATE | 0.6 MG / ML |
| Marketed | 02507668 | HIKMA CANADA LIMITED | AZACITIDINE FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | AZACITIDINE | 100 MG / VIAL |
| Dormant | 02457059 | HIKMA CANADA LIMITED | BACLOFEN INJECTION | Human | Yes | PRESCRIPTION | 1 | BACLOFEN | 0.05 MG / ML |
| Dormant | 02457067 | HIKMA CANADA LIMITED | BACLOFEN INJECTION | Human | Yes | PRESCRIPTION | 1 | BACLOFEN | 0.5 MG / ML |
| Marketed | 02457075 | HIKMA CANADA LIMITED | BACLOFEN INJECTION | Human | Yes | PRESCRIPTION | 1 | BACLOFEN | 2 MG / ML |
| Approved | 02526972 | HIKMA CANADA LIMITED | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | BENDAMUSTINE HYDROCHLORIDE | 25 MG / VIAL |
| Approved | 02526980 | HIKMA CANADA LIMITED | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | BENDAMUSTINE HYDROCHLORIDE | 100 MG / VIAL |
| Approved | 02547287 | HIKMA CANADA LIMITED | BORTEZOMIB FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) | 3.5 MG / VIAL |
| Cancelled Post Market | 02515377 | HIKMA CANADA LIMITED | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | Human | Yes | PRESCRIPTION | 1 | BRIMONIDINE TARTRATE | 0.2 % / W/V |
| Approved | 02569094 | HIKMA CANADA LIMITED | BUPIVACAINE HYDROCHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | BUPIVACAINE HYDROCHLORIDE | 2.5 MG / ML |
| Approved | 02569108 | HIKMA CANADA LIMITED | BUPIVACAINE HYDROCHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | BUPIVACAINE HYDROCHLORIDE | 5 MG / ML |
| Marketed | 02437104 | HIKMA CANADA LIMITED | CEFAZOLIN FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | CEFAZOLIN (CEFAZOLIN SODIUM) | 500 MG / VIAL |
| Marketed | 02437112 | HIKMA CANADA LIMITED | CEFAZOLIN FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | CEFAZOLIN (CEFAZOLIN SODIUM) | 1 G / VIAL |
| Marketed | 02437120 | HIKMA CANADA LIMITED | CEFAZOLIN FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | CEFAZOLIN (CEFAZOLIN SODIUM) | 10 G / VIAL |
| Approved | 02499088 | HIKMA CANADA LIMITED | CEFEPIME FOR INJECTION USP | Human | Yes | PRESCRIPTION | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 1 G / VIAL |
| Marketed | 02499096 | HIKMA CANADA LIMITED | CEFEPIME FOR INJECTION USP | Human | Yes | PRESCRIPTION | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 2 G / VIAL |
| Dormant | 02422298 | HIKMA CANADA LIMITED | CEFUROXIME FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | CEFUROXIME (CEFUROXIME SODIUM) | 750 MG / VIAL |
| Dormant | 02422301 | HIKMA CANADA LIMITED | CEFUROXIME FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | CEFUROXIME (CEFUROXIME SODIUM) | 1.5 G / VIAL |
| Dormant | 02422328 | HIKMA CANADA LIMITED | CEFUROXIME FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | CEFUROXIME (CEFUROXIME SODIUM) | 7.5 G / VIAL |
| Approved | 02557665 | HIKMA CANADA LIMITED | CISATRACURIUM BESYLATE INJECTION, USP MULTI-DOSE | Human | Yes | PRESCRIPTION | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
| Marketed | 02536285 | HIKMA CANADA LIMITED | CISPLATIN INJECTION BP | Human | Yes | PRESCRIPTION | 1 | CISPLATIN | 1 MG / ML |
| Dormant | 02483769 | HIKMA CANADA LIMITED | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP | Human | Yes | PRESCRIPTION | 1 | CLINDAMYCIN (CLINDAMYCIN PHOSPHATE) | 1 % / W/V |
| Marketed | 02463393 | HIKMA CANADA LIMITED | CYANOCOBALAMIN INJECTION USP | Human | Yes | ETHICAL | 1 | VITAMIN B12 | 1000 MCG / ML |
| Marketed | 02465507 | HIKMA CANADA LIMITED | CYANOCOBALAMIN INJECTION USP | Human | Yes | ETHICAL | 1 | VITAMIN B12 | 1000 MCG / ML |
| Marketed | 02529998 | HIKMA CANADA LIMITED | DANTROLENE SODIUM FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | DANTROLENE SODIUM | 20 MG / VIAL |
| Marketed | 02539209 | HIKMA CANADA LIMITED | DAUNORUBICIN HYDROCHLORIDE INJECTION | Human | Yes | PRESCRIPTION | 1 | DAUNORUBICIN (DAUNORUBICIN HYDROCHLORIDE) | 20 MG / 4 ML |
| Approved | 02537095 | HIKMA CANADA LIMITED | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP | Human | Yes | PRESCRIPTION | 1 | DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) | 100 MCG / ML |
| Marketed | 02537109 | HIKMA CANADA LIMITED | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | Human | Yes | PRESCRIPTION | 1 | DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE) | 4 MCG / ML |
| Marketed | 02557649 | HIKMA CANADA LIMITED | DEXRAZOXANE FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | DEXRAZOXANE | 250 MG / VIAL |
| Dormant | 02385392 | HIKMA CANADA LIMITED | DIAZEPAM INJECTION USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | DIAZEPAM | 5 MG / ML |
| Dormant | 02476134 | HIKMA CANADA LIMITED | DICLOFENAC SODIUM SOLUTION | Human | Yes | PRESCRIPTION | 1 | DICLOFENAC SODIUM | 1.5 % / W/W |
| Marketed | 02428954 | HIKMA CANADA LIMITED | DIMENHYDRINATE INJECTION USP | Human | Yes | ETHICAL | 1 | DIMENHYDRINATE | 50 MG / 1 ML |
| Marketed | 02435241 | HIKMA CANADA LIMITED | DIMENHYDRINATE INJECTION USP | Human | Yes | ETHICAL | 1 | DIMENHYDRINATE | 250 MG / 5 ML |
| Marketed | 02462729 | HIKMA CANADA LIMITED | DOBUTAMINE INJECTION USP | Human | Yes | PRESCRIPTION | 1 | DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) | 12.5 MG / ML |
| Cancelled Post Market | 02489635 | HIKMA CANADA LIMITED | DORZOLAMIDE AND TIMOLOL EYE DROPS BP | Human | Yes | PRESCRIPTION | 2 | DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE) | 20 MG / ML |
| Cancelled Pre Market | 02489260 | HIKMA CANADA LIMITED | DORZOLAMIDE EYE DROPS BP | Human | Yes | PRESCRIPTION | 1 | DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE) | 2 % / W/V |
| Marketed | 02388499 | HIKMA CANADA LIMITED | ENALAPRILAT INJECTION USP | Human | Yes | PRESCRIPTION | 1 | ENALAPRILAT | 1.25 MG / ML |
| Marketed | 02435810 | HIKMA CANADA LIMITED | EPINEPHRINE INJECTION USP | Human | Yes | ETHICAL | 1 | EPINEPHRINE | 1 MG / 1 ML |
| Marketed | 02441241 | HIKMA CANADA LIMITED | ERGONOVINE MALEATE INJECTION USP | Human | Yes | PRESCRIPTION | 1 | ERGONOVINE MALEATE | 0.25 MG / ML |
| Approved | 02505126 | HIKMA CANADA LIMITED | ERTAPENEM FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | ERTAPENEM (ERTAPENEM SODIUM) | 1 G / VIAL |
| Marketed | 02552671 | HIKMA CANADA LIMITED | ETOPOSIDE INJECTION | Human | Yes | PRESCRIPTION | 1 | ETOPOSIDE | 20 MG / ML |
| Dormant | 02385406 | HIKMA CANADA LIMITED | FENTANYL CITRATE INJECTION USP | Human | Yes | NARCOTICS (CDSA I) | 1 | FENTANYL (FENTANYL CITRATE) | 50 MCG / ML |
| Marketed | 02384094 | HIKMA CANADA LIMITED | FUROSEMIDE INJECTION USP | Human | Yes | PRESCRIPTION | 1 | FUROSEMIDE | 20 MG / 2 ML |
| Approved | 02565641 | HIKMA CANADA LIMITED | GEMCITABINE INJECTION | Human | Yes | PRESCRIPTION | 1 | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) | 38 MG / ML |
| Marketed | 02457008 | HIKMA CANADA LIMITED | GENTAMICIN INJECTION USP | Human | Yes | PRESCRIPTION | 1 | GENTAMICIN (GENTAMICIN SULFATE) | 40 MG / ML |
| Marketed | 02470462 | HIKMA CANADA LIMITED | GENTAMICIN INJECTION USP | Human | Yes | PRESCRIPTION | 1 | GENTAMICIN (GENTAMICIN SULFATE) | 10 MG / ML |
| Approved | 02558408 | HIKMA CANADA LIMITED | GRANISETRON HYDROCHLORIDE INJECTION USP | Human | Yes | PRESCRIPTION | 1 | GRANISETRON (GRANISETRON HYDROCHLORIDE) | 1 MG / ML |
| Approved | 02564378 | HIKMA CANADA LIMITED | HALOPERIDOL DECANOATE LA INJECTION | Human | Yes | PRESCRIPTION | 1 | HALOPERIDOL (HALOPERIDOL DECANOATE) | 50 MG / ML |
| Approved | 02564386 | HIKMA CANADA LIMITED | HALOPERIDOL DECANOATE LA INJECTION | Human | Yes | PRESCRIPTION | 1 | HALOPERIDOL (HALOPERIDOL DECANOATE) | 100 MG / ML |
| Approved | 02497530 | HIKMA CANADA LIMITED | HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION USP | Human | Yes | PRESCRIPTION | 1 | HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE) | 100 MG / VIAL |
| Approved | 02497549 | HIKMA CANADA LIMITED | HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION USP | Human | Yes | PRESCRIPTION | 1 | HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE) | 250 MG / VIAL |
| Approved | 02555441 | HIKMA CANADA LIMITED | KLOXXADO | Human | Yes | PRESCRIPTION | 1 | NALOXONE HYDROCHLORIDE | 8 MG / 0.1 ML |
| Approved | 02562723 | HIKMA CANADA LIMITED | KYZATREX | Human | Yes | CONTROLLED DRUGS (CDSA IV) | 1 | TESTOSTERONE UNDECANOATE | 100 MG |
| Approved | 02562731 | HIKMA CANADA LIMITED | KYZATREX | Human | Yes | CONTROLLED DRUGS (CDSA IV) | 1 | TESTOSTERONE UNDECANOATE | 150 MG |
| Approved | 02562758 | HIKMA CANADA LIMITED | KYZATREX | Human | Yes | CONTROLLED DRUGS (CDSA IV) | 1 | TESTOSTERONE UNDECANOATE | 200 MG |
| Approved | 02557037 | HIKMA CANADA LIMITED | LABETALOL HYDROCHLORIDE INJECTION IN 0.72% SODIUM CHLORIDE | Human | Yes | PRESCRIPTION | 1 | LABETALOL HYDROCHLORIDE | 1 MG / ML |
| Approved | 02557029 | HIKMA CANADA LIMITED | LABETALOL HYDROCHLORIDE INJECTION IN 5% DEXTROSE | Human | Yes | PRESCRIPTION | 1 | LABETALOL HYDROCHLORIDE | 1 MG / ML |
| Dormant | 02541343 | HIKMA CANADA LIMITED | LACOSAMIDE INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | LACOSAMIDE | 10 MG / ML |
| Cancelled Post Market | 02489368 | HIKMA CANADA LIMITED | LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | Human | Yes | PRESCRIPTION | 2 | LATANOPROST | 50 MCG / ML |
| Cancelled Post Market | 02489570 | HIKMA CANADA LIMITED | LATANOPROST OPHTHALMIC SOLUTION | Human | Yes | PRESCRIPTION | 1 | LATANOPROST | 50 MCG / ML |
| Approved | 02565854 | HIKMA CANADA LIMITED | LEUCOVORIN CALCIUM INJECTION USP | Human | Yes | PRESCRIPTION | 1 | LEUCOVORIN (LEUCOVORIN CALCIUM) | 10 MG / ML |
| Approved | 02565862 | HIKMA CANADA LIMITED | LEUCOVORIN CALCIUM INJECTION USP | Human | Yes | PRESCRIPTION | 1 | LEUCOVORIN (LEUCOVORIN CALCIUM) | 10 MG / ML |
| Marketed | 02537079 | HIKMA CANADA LIMITED | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | Human | Yes | PRESCRIPTION | 1 | LEVOFLOXACIN | 5 MG / ML |
| Approved | 02489554 | HIKMA CANADA LIMITED | LIDOCAINE HCL TOPICAL SOLUTION | Human | Yes | ETHICAL | 1 | LIDOCAINE HYDROCHLORIDE | 40 MG / ML |
| Marketed | 02436221 | HIKMA CANADA LIMITED | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | Human | Yes | ETHICAL | 2 | LIDOCAINE HYDROCHLORIDE | 20 MG / ML |
| Marketed | 02421984 | HIKMA CANADA LIMITED | LIDOCAINE HYDROCHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | LIDOCAINE HYDROCHLORIDE | 10 MG / ML |
| Marketed | 02421992 | HIKMA CANADA LIMITED | LIDOCAINE HYDROCHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | LIDOCAINE HYDROCHLORIDE | 20 MG / ML |
| Marketed | 02422018 | HIKMA CANADA LIMITED | LIDOCAINE HYDROCHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | LIDOCAINE HYDROCHLORIDE | 10 MG / ML |
| Marketed | 02422026 | HIKMA CANADA LIMITED | LIDOCAINE HYDROCHLORIDE INJECTION USP | Human | Yes | ETHICAL | 1 | LIDOCAINE HYDROCHLORIDE | 20 MG / ML |
| Dormant | 02458128 | HIKMA CANADA LIMITED | LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP | Human | No | NON-PRESCRIPTION DRUGS | 1 | LIDOCAINE HYDROCHLORIDE | 4 % / W/V |
| Approved | 02458209 | HIKMA CANADA LIMITED | LIDOCAINE OINTMENT USP | Human | No | NON-PRESCRIPTION DRUGS | 1 | LIDOCAINE | 5 % / W/W |
| Cancelled Post Market | 02431548 | HIKMA CANADA LIMITED | METHYLENE BLUE INJECTION USP | Human | Yes | ETHICAL | 1 | METHYLENE BLUE | 10 MG / ML |
| Approved | 02565595 | HIKMA CANADA LIMITED | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE) | 40 MG / VIAL |
| Approved | 02565609 | HIKMA CANADA LIMITED | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE) | 125 MG / VIAL |
| Marketed | 02532344 | HIKMA CANADA LIMITED | MICAFUNGIN SODIUM FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | MICAFUNGIN SODIUM | 50 MG / VIAL |
| Marketed | 02532360 | HIKMA CANADA LIMITED | MICAFUNGIN SODIUM FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | MICAFUNGIN SODIUM | 100 MG / VIAL |
| Marketed | 02553104 | HIKMA CANADA LIMITED | MIDAZOLAM INJECTION USP | Human | Yes | TARGETED SUBSTANCES (CDSA IV) | 1 | MIDAZOLAM | 1 MG / ML |
| Marketed | 02531941 | HIKMA CANADA LIMITED | MITOMYCIN FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | MITOMYCIN | 20 MG / VIAL |
| Approved | 02562197 | HIKMA CANADA LIMITED | MOXIFLOXACIN INJECTION | Human | Yes | PRESCRIPTION | 1 | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) | 400 MG / 250 ML |
| Marketed | 02382482 | HIKMA CANADA LIMITED | NALOXONE HYDROCHLORIDE INJECTION USP | Human | Yes | PRESCRIPTION | 1 | NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE) | 0.4 MG / ML |
| Marketed | 02458578 | HIKMA CANADA LIMITED | NALOXONE INJECTABLE | Human | Yes | ETHICAL | 1 | NALOXONE HYDROCHLORIDE | 0.4 MG / ML |
| Approved | 02568578 | HIKMA CANADA LIMITED | OLANZAPINE FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | OLANZAPINE (OLANZAPINE TARTRATE) | 10 MG / VIAL |
| Marketed | 02550199 | HIKMA CANADA LIMITED | OXYTOCIN INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | OXYTOCIN | 10 UNIT / ML |
| Approved | 02554534 | HIKMA CANADA LIMITED | PEMETREXED DISODIUM FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) | 100 MG / VIAL |
| Approved | 02554542 | HIKMA CANADA LIMITED | PEMETREXED DISODIUM FOR INJECTION | Human | Yes | PRESCRIPTION | 1 | PEMETREXED (PEMETREXED DISODIUM HEMIPENTAHYDRATE) | 500 MG / VIAL |
| Marketed | 02431378 | HIKMA CANADA LIMITED | PHENYTOIN SODIUM INJECTION USP | Human | Yes | PRESCRIPTION | 1 | PHENYTOIN SODIUM | 50 MG / ML |
| Cancelled Post Market | 02401312 | HIKMA CANADA LIMITED | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Human | Yes | PRESCRIPTION | 2 | PIPERACILLIN (PIPERACILLIN SODIUM) | 2 G / VIAL |
| Cancelled Post Market | 02401320 | HIKMA CANADA LIMITED | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Human | Yes | PRESCRIPTION | 2 | PIPERACILLIN (PIPERACILLIN SODIUM) | 3 G / VIAL |
| Cancelled Post Market | 02401339 | HIKMA CANADA LIMITED | PIPERACILLIN AND TAZOBACTAM FOR INJECTION | Human | Yes | PRESCRIPTION | 2 | PIPERACILLIN (PIPERACILLIN SODIUM) | 4 G / VIAL |
| Marketed | 02531828 | HIKMA CANADA LIMITED | PROGESTERONE INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | PROGESTERONE | 50 MG / ML |
| Marketed | 02517744 | HIKMA CANADA LIMITED | ROCURONIUM BROMIDE INJECTION | Human | Yes | PRESCRIPTION | 1 | ROCURONIUM BROMIDE | 10 MG / ML |
| Marketed | 02299186 | HIKMA CANADA LIMITED | STERILE WATER FOR INJECTION USP | Human | Yes | ETHICAL | 1 | WATER | 100 % |
| Marketed | 02422336 | HIKMA CANADA LIMITED | SUCCINYLCHOLINE CHLORIDE INJECTION USP | Human | Yes | PRESCRIPTION | 1 | SUCCINYLCHOLINE CHLORIDE | 20 MG / ML |
| Approved | 02483181 | HIKMA CANADA LIMITED | SUFENTANIL CITRATE INJECTION | Human | Yes | NARCOTICS (CDSA I) | 1 | SUFENTANIL (SUFENTANIL CITRATE) | 50 MCG / ML |
| Marketed | 02536315 | HIKMA CANADA LIMITED | TESTOSTERONE ENANTHATE INJECTION, USP | Human | Yes | CONTROLLED DRUGS (CDSA IV) | 1 | TESTOSTERONE ENANTHATE | 200 MG / ML |
| Marketed | 02536862 | HIKMA CANADA LIMITED | THIOTEPA FOR INJECTION, BP | Human | Yes | PRESCRIPTION | 1 | THIOTEPA | 15 MG / VIAL |
| Marketed | 02536870 | HIKMA CANADA LIMITED | THIOTEPA FOR INJECTION, BP | Human | Yes | PRESCRIPTION | 1 | THIOTEPA | 100 MG / VIAL |
| Approved | 02531127 | HIKMA CANADA LIMITED | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 5 G / VIAL |
| Approved | 02531135 | HIKMA CANADA LIMITED | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 10 G / VIAL |
| Marketed | 02543974 | HIKMA CANADA LIMITED | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 500 MG / VIAL |
| Marketed | 02543982 | HIKMA CANADA LIMITED | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | Human | Yes | PRESCRIPTION | 1 | VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE) | 1 G / VIAL |
Application information
Related information
Contact us
Version 4.1.0